HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Matsumoto Selected Research

Liposomes (Liposome)

3/2021Molecular mechanism underlying the selective attack of trehalose lipids on cancer cells as revealed by coarse-grained molecular dynamics simulations.
11/2020Trehalose liposomes induce apoptosis of breast tumor cells in vitro and in vivo.
1/2019Therapeutic effects and anti-metastasis effects of cationic liposomes against pancreatic cancer metastasis in vitro and in vivo.
1/2019Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cells.
11/2018Hybrid liposomes showing enhanced accumulation in tumors as theranostic agents in the orthotopic graft model mouse of colorectal cancer.
10/2018Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
1/2018Nano-chemotherapy using cationic liposome that strategically targets the cell membrane potential of pancreatic cancer cells with negative charge.
11/2017Trehalose Liposomes Suppress the Growth of Tumors on Human Lung Carcinoma-bearing Mice by Induction of Apoptosis In Vivo.
11/2016Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation.
1/2016Therapeutic effects of trehalose liposomes against lymphoblastic leukemia leading to apoptosis in vitro and in vivo.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Matsumoto Research Topics

Disease

52Neoplasms (Cancer)
09/2022 - 04/2002
24Carcinoma (Carcinomatosis)
10/2020 - 04/2002
13Neoplasm Metastasis (Metastasis)
12/2019 - 04/2009
9Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021 - 01/2013
8Endometrial Neoplasms (Endometrial Cancer)
08/2020 - 01/2007
7Macular Degeneration (Age-Related Maculopathy)
10/2008 - 01/2002
6Breast Neoplasms (Breast Cancer)
11/2020 - 02/2006
4Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 11/2012
4Choroidal Neovascularization
10/2008 - 09/2006
3Infections
11/2021 - 02/2014
3Carcinogenesis
08/2021 - 01/2012
3Body Weight (Weight, Body)
10/2020 - 04/2019
3Lung Neoplasms (Lung Cancer)
11/2019 - 01/2016
3Rheumatoid Arthritis
07/2015 - 01/2011
3Atrophy
07/2014 - 05/2004
3Lymphoma (Lymphomas)
04/2009 - 06/2006
2Lung Diseases (Lung Disease)
11/2021 - 06/2018
2Hypersensitivity (Allergy)
11/2020 - 01/2013
2Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 02/2010
2Ascites
10/2020 - 04/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 04/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2018
2Lymphatic Metastasis
04/2016 - 01/2007
2Arthritis (Polyarthritis)
07/2015 - 01/2011
2Hepatocellular Carcinoma (Hepatoma)
01/2012 - 11/2002
2Neuroblastoma
04/2011 - 01/2011
2Leukemia
03/2011 - 06/2005
2Macular Edema
07/2010 - 04/2007
2Polypoidal Choroidal Vasculopathy
07/2007 - 09/2006
2Melanoma (Melanoma, Malignant)
09/2004 - 01/2003
1Toxic Optic Neuropathy
11/2021

Drug/Important Bio-Agent (IBA)

46Liposomes (Liposome)IBA
03/2021 - 04/2002
28Dimyristoylphosphatidylcholine (DMPC)IBA
03/2021 - 04/2002
17Therapeutic UsesIBA
01/2019 - 04/2009
11Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 - 11/2002
9Ether (Diethyl Ether)IBA
01/2019 - 11/2002
8Pharmaceutical PreparationsIBA
06/2021 - 04/2002
6Proteins (Proteins, Gene)FDA Link
04/2019 - 03/2013
5TrehaloseIBA
03/2021 - 01/2013
51-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2008 - 09/2006
4Biomarkers (Surrogate Marker)IBA
10/2019 - 03/2014
4polyoxyethylene(25)dodecyl etherIBA
10/2018 - 11/2012
4Surface-Active Agents (Surfactants)IBA
01/2016 - 04/2002
4polyoxyethylene (23) dodecyletherIBA
07/2015 - 03/2005
4Retinaldehyde (Retinal)IBA
02/2008 - 05/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 04/2007
3LipidsIBA
06/2021 - 09/2008
3Bevacizumab (Avastin)FDA Link
06/2021 - 04/2007
3dihydroceramide desaturaseIBA
11/2019 - 01/2016
3Messenger RNA (mRNA)IBA
10/2019 - 01/2007
3UbiquitinIBA
06/2016 - 04/2006
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2014 - 03/2008
3Polysorbates (PSML)FDA Link
07/2008 - 04/2002
2Carboplatin (JM8)FDA LinkGeneric
11/2020 - 01/2013
2EverolimusFDA Link
10/2020 - 01/2012
2Monoclonal AntibodiesIBA
09/2020 - 04/2007
2DNA (Deoxyribonucleic Acid)IBA
05/2020 - 03/2014
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2020 - 03/2014
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 01/2012
2Histone MethyltransferasesIBA
05/2019 - 01/2019
2ChloridesIBA
01/2019 - 01/2014
2diethanolamineIBA
01/2019 - 01/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 03/2014
2Fluorescent Dyes (Fluorescent Probes)IBA
11/2018 - 10/2018
2Estrogens (Estrogen)FDA Link
11/2018 - 01/2016
2Caspase 3 (Caspase-3)IBA
01/2018 - 06/2005
2Eosine Yellowish-(YS) (Eosin)IBA
11/2017 - 07/2010
2Hematoxylin (Haematoxylon)IBA
11/2017 - 07/2010
2MicellesIBA
10/2016 - 06/2016
2Antineoplastic Agents (Antineoplastics)IBA
06/2016 - 09/2008
2Oncogene Proteins (Oncogene Protein)IBA
04/2015 - 07/2008
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2011 - 02/2006
2Fluorescein (Funduscein)FDA LinkGeneric
07/2010 - 01/2007
2Docosahexaenoic AcidsIBA
07/2008 - 03/2008
2sorbitan monooleate (Span 80)IBA
07/2008 - 03/2008
2CaspasesIBA
07/2008 - 02/2006
2Verteporfin (Visudyne)FDA Link
07/2007 - 09/2006
2Polidocanol (Laureth)FDA Link
03/2005 - 01/2003
1Ethambutol (Myambutol)FDA LinkGeneric
11/2021
11-dodecylpyridoxal (PLD)IBA
06/2021
1liposomal doxorubicin (Doxil)FDA Link
06/2021
1Cisplatin (Platino)FDA LinkGeneric
06/2021
1Lipid Bilayers (Lipid Bilayer)IBA
03/2021
1MTOR InhibitorsIBA
10/2020

Therapy/Procedure

13Therapeutics
11/2021 - 09/2006
13Drug Therapy (Chemotherapy)
06/2021 - 06/2006
5Photochemotherapy (Photodynamic Therapy)
10/2008 - 09/2006
4Intravenous Injections
10/2016 - 07/2010
4Aftercare (After-Treatment)
09/2014 - 03/2008
2Palliative Care (Palliative Therapy)
09/2022 - 05/2010
2Radiotherapy
11/2019 - 01/2019
2Hysterectomy
08/2019 - 04/2016
2Intravenous Administration
11/2018 - 10/2018
2Precision Medicine
11/2018 - 10/2018
2Retreatment
01/2013 - 07/2010
2Vitrectomy
02/2004 - 01/2002
1Combination Drug Therapy (Combination Chemotherapy)
11/2021
1Cell Transplantation
08/2021
1Drug Tapering
10/2020